ARCHIVES

Trial In Metastatic Disease To Be Unblinded After Regorafenib Meets Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | November 25, 2011

Download PDF Visit The Full Archive

Related Articles

Six More Clinical Trials Proposed For High Priority Status, But Per Case Funds For Them Not Assured

June 16, 1989

Rays Of Hope Candlelight Vigil Scheduled For Oct. 6.

September 8, 2000

In Brief: DCBD Board Adds Concept Review To Duties, Rabson Seeks Four Additional Member

September 19, 1980

Decision to Cover New Colorectal Cancer Drugs, PET Scans.

February 4, 2005

DCPC Concepts Approved

September 27, 1985

Tumor Treating Fields Therapy Increased Three-Year Survival

November 25, 2011